236 related articles for article (PubMed ID: 28143725)
1. Methylation at 3'LCR of HPV16 can be affected by patient age and disruption of E1 or E2 genes.
Filho SMA; Bertoni N; Brant AC; Vidal JPCB; Felix SP; Cavalcanti SMB; Carestiato FN; Martins LFL; Almeida LM; Moreira MAM
Virus Res; 2017 Mar; 232():48-53. PubMed ID: 28143725
[TBL] [Abstract][Full Text] [Related]
2. HPV DNA methylation at the early promoter and E1/E2 integrity: A comparison between HPV16, HPV18 and HPV45 in cervical cancer.
Amaro-Filho SM; Pereira Chaves CB; Felix SP; Basto DL; de Almeida LM; Moreira MAM
Papillomavirus Res; 2018 Jun; 5():172-179. PubMed ID: 29649654
[TBL] [Abstract][Full Text] [Related]
3. Methylation of p16 ink4a promoter is independent of human papillomavirus DNA physical state: a comparison between cervical pre-neoplastic and neoplastic samples.
Carestiato FN; Amaro-Filho SM; Moreira MAM; Cavalcanti SMB
Mem Inst Oswaldo Cruz; 2018 Dec; 114():e180456. PubMed ID: 30569945
[TBL] [Abstract][Full Text] [Related]
4. Methylation status of HPV16 E2-binding sites classifies subtypes of HPV-associated oropharyngeal cancers.
Reuschenbach M; Huebbers CU; Prigge ES; Bermejo JL; Kalteis MS; Preuss SF; Seuthe IM; Kolligs J; Speel EJ; Olthof N; Kremer B; Wagner S; Klussmann JP; Vinokurova S; von Knebel Doeberitz M
Cancer; 2015 Jun; 121(12):1966-76. PubMed ID: 25731880
[TBL] [Abstract][Full Text] [Related]
5. Situation of HPV16 E2 gene status during radiotherapy treatment of cervical carcinoma.
Kahla S; Kochbati L; Maalej M; Oueslati R
Asian Pac J Cancer Prev; 2014; 15(6):2869-73. PubMed ID: 24761916
[TBL] [Abstract][Full Text] [Related]
6. Virological characteristics of cervical cancers carrying pure episomal form of HPV16 genome.
Cheung JL; Cheung TH; Yu MY; Chan PK
Gynecol Oncol; 2013 Nov; 131(2):374-9. PubMed ID: 24012799
[TBL] [Abstract][Full Text] [Related]
7. HPV prevalence, E6 sequence variation and physical state of HPV16 isolates from patients with cervical cancer in Sichuan, China.
Qiu AD; Wu EQ; Yu XH; Jiang CL; Jin YH; Wu YG; Chen Y; Chen Y; Shan YM; Zhang GN; Fan Y; Zha X; Kong W
Gynecol Oncol; 2007 Jan; 104(1):77-85. PubMed ID: 16970982
[TBL] [Abstract][Full Text] [Related]
8. Viral DNA load, physical status and E2/E6 ratio as markers to grade HPV16 positive women for high-grade cervical lesions.
Cricca M; Morselli-Labate AM; Venturoli S; Ambretti S; Gentilomi GA; Gallinella G; Costa S; Musiani M; Zerbini M
Gynecol Oncol; 2007 Sep; 106(3):549-57. PubMed ID: 17568661
[TBL] [Abstract][Full Text] [Related]
9. Physical and methylation status of human papillomavirus 16 in asymptomatic cervical infections changes with malignant transformation.
Dutta S; Chakraborty C; Dutta AK; Mandal RK; Roychoudhury S; Basu P; Panda CK
J Clin Pathol; 2015 Mar; 68(3):206-11. PubMed ID: 25563334
[TBL] [Abstract][Full Text] [Related]
10. Impact of viral and host DNA methylations on HPV16-related cervical cancer pathogenesis.
Sen S; Mandal P; Bhattacharya A; Kundu S; Roy Chowdhury R; Mondal NR; Chatterjee T; Chakravarty B; Roy S; Sengupta S
Tumour Biol; 2017 May; 39(5):1010428317699799. PubMed ID: 28459195
[TBL] [Abstract][Full Text] [Related]
11. CpG methylation of HPV 16 LCR at E2 binding site proximal to P97 is associated with cervical cancer in presence of intact E2.
Bhattacharjee B; Sengupta S
Virology; 2006 Oct; 354(2):280-5. PubMed ID: 16905170
[TBL] [Abstract][Full Text] [Related]
12. Viral E6 is overexpressed via high viral load in invasive cervical cancer with episomal HPV16.
Hong D; Liu J; Hu Y; Lu X; Li B; Li Y; Hu D; Lu W; Xie X; Cheng X
BMC Cancer; 2017 Feb; 17(1):136. PubMed ID: 28202002
[TBL] [Abstract][Full Text] [Related]
13. Differential expression of HPV16 L2 gene in cervical cancers harboring episomal HPV16 genomes: influence of synonymous and non-coding region variations.
Mandal P; Bhattacharjee B; Das Ghosh D; Mondal NR; Roy Chowdhury R; Roy S; Sengupta S
PLoS One; 2013; 8(6):e65647. PubMed ID: 23762404
[TBL] [Abstract][Full Text] [Related]
14. Genetic and epigenetic changes of HPV16 in cervical cancer differentially regulate E6/E7 expression and associate with disease progression.
Mazumder Indra D; Singh RK; Mitra S; Dutta S; Chakraborty C; Basu PS; Mondal RK; Roychoudhury S; Panda CK
Gynecol Oncol; 2011 Dec; 123(3):597-604. PubMed ID: 21911249
[TBL] [Abstract][Full Text] [Related]
15. Methylation of human papillomavirus Type 16 CpG sites at E2-binding site 1 (E2BS1), E2BS2, and the Sp1-binding site in cervical cancer samples as determined by high-resolution melting analysis-PCR.
Jacquin E; Baraquin A; Ramanah R; Carcopino X; Morel A; Valmary-Degano S; Bravo IG; de Sanjosé S; Riethmuller D; Mougin C; Prétet JL
J Clin Microbiol; 2013 Oct; 51(10):3207-15. PubMed ID: 23863566
[TBL] [Abstract][Full Text] [Related]
16. Polymorphisms and functional analysis of the intact human papillomavirus16 e2 gene.
Ekalaksananan T; Jungpol W; Prasitthimay C; Wongjampa W; Kongyingyoes B; Pientong C
Asian Pac J Cancer Prev; 2014; 15(23):10255-62. PubMed ID: 25556457
[TBL] [Abstract][Full Text] [Related]
17. Quantitative real-time polymerase chain reaction analysis of the type distribution, viral load, and physical status of human papillomavirus in liquid-based cytology samples from cervical lesions.
Yoshida T; Sano T; Kanuma T; Owada N; Sakurai S; Fukuda T; Nakajima T
Int J Gynecol Cancer; 2008; 18(1):121-7. PubMed ID: 17506843
[TBL] [Abstract][Full Text] [Related]
18. Determination of human papillomavirus 16 physical status through E1/E6 and E2/E6 ratio analysis.
Tsakogiannis D; Kyriakopoulou Z; Ruether IGA; Amoutzias GD; Dimitriou TG; Diamantidou V; Kotsovassilis C; Markoulatos P
J Med Microbiol; 2014 Dec; 63(Pt 12):1716-1723. PubMed ID: 25212758
[TBL] [Abstract][Full Text] [Related]
19. [Analysis on the expression of human papillomavirus type 16 E2 and E6 oncogenes and disruption of E2 in cervical cancer].
Wang JT; Ding L; Gao ES; Cheng YY
Zhonghua Liu Xing Bing Xue Za Zhi; 2007 Oct; 28(10):968-71. PubMed ID: 18399141
[TBL] [Abstract][Full Text] [Related]
20. HPV16 oncogenes E6 or/and E7 may influence the methylation status of RASSFIA gene promoter region in cervical cancer cell line HT-3.
Yin F; Wang N; Wang S; Yu F; Sun X; Yu X; Luo B; Zhao C; Wang Y
Oncol Rep; 2017 Apr; 37(4):2324-2334. PubMed ID: 28260046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]